Real-time monitoring of cell health, metabolic activity, and drug responses in organ-on-chip systems through integrated electrochemical, optical, and electrical sensing
What Are Biosensors?
Biosensors are analytical devices that combine a biological recognition element (enzymes, antibodies, cells, or nucleic acids) with a physicochemical transducer to detect and quantify specific biological or chemical substances. In the context of organ-on-chip and drug discovery, biosensors enable continuous, real-time monitoring of cellular health, metabolic activity, barrier integrity, and drug responses without disrupting the biological system.
Unlike endpoint assays that provide snapshots at specific times, integrated biosensors deliver dynamic data streams that capture the kinetics of cellular responses - revealing how quickly cells respond to drugs, when toxicity begins, and how cells recover over time. This temporal resolution is critical for understanding drug mechanisms and predicting clinical outcomes.
90%of drugs fail in clinical trials - better sensors can identify failures earlier
Minutesto detect toxicity vs. days with traditional methods
10xmore data points per experiment with continuous monitoring
FDAaccepts sensor data from organ-on-chip for IND applications
Emulate's liver-on-chip with integrated oxygen sensors detected drug-induced mitochondrial toxicity 48 hours before visible cell death occurred - the kind of early warning that could have prevented clinical failures like troglitazone (Rezulin), which was withdrawn after causing liver failure in patients.
Integrated Sensing in Organ-on-Chip
O2
pH
TEER
Glucose
Lactate
Multiple sensors monitoring cell health parameters simultaneously in real-time
Types of Biosensors
Different transduction mechanisms offer unique advantages for monitoring specific cellular parameters. The choice of sensor type depends on the analyte of interest, required sensitivity, and integration constraints.
Electrochemical
Convert chemical reactions to electrical signals using enzyme-coated electrodes. Highly sensitive and amenable to miniaturization. Used for metabolites like glucose, lactate, and reactive oxygen species.
Detection: nM-mM range | Response: seconds | Size: micrometer electrodes
Optical
Use fluorescent or luminescent probes that change optical properties in response to analytes. Non-contact measurement through transparent chips. Ideal for oxygen, pH, and calcium imaging.
Detect mass changes through resonant frequency shifts in quartz crystals (QCM). Measures cell attachment, spreading, and receptor-ligand binding without labels.
Mass detection: ng/cm2 | Response: real-time | Label-free operation
Thermal
Measure heat generated or absorbed during biochemical reactions using thermistors or thermopiles. Detect enzymatic activity and metabolic rate changes.
Sensitivity: mK range | Universal: all reactions produce heat
TEER Measurements
Trans-Epithelial/Endothelial Electrical Resistance (TEER) is the gold standard for assessing barrier integrity in cell monolayers. It measures the electrical resistance across a cell layer, which correlates with tight junction formation and paracellular permeability.
Why TEER Matters
Barrier Function: Tight junctions between cells control what passes through tissue barriers. TEER provides a non-invasive, real-time measure of this critical function.
Drug Permeability: Intestinal models use TEER to predict oral drug absorption. Blood-brain barrier models assess CNS drug penetration.
Toxicity Detection: Many drugs disrupt tight junctions, and TEER can detect this damage within minutes - far earlier than cell death assays.
Tissue Maturation: Rising TEER values indicate cells are differentiating and forming functional barriers, confirming model quality.
A pharmaceutical company used TEER-integrated gut-on-chip to screen NSAIDs (non-steroidal anti-inflammatory drugs) for intestinal toxicity. Continuous TEER monitoring detected barrier disruption from indomethacin within 2 hours of exposure - correlating with the known clinical side effect of GI bleeding. Control compounds that don't cause GI issues showed stable TEER values.
2 hrs
Time to detect toxicity
85%
Correlation with clinical GI risk
12
Compounds screened per day
$2M
Saved by early compound termination
Oxygen Sensing
Oxygen is fundamental to cellular metabolism, and its consumption rate directly reflects metabolic activity, mitochondrial function, and cell viability. Optical oxygen sensors have become essential tools in organ-on-chip systems.
How Optical Oxygen Sensors Work
Oxygen-sensitive fluorescent dyes (typically ruthenium or platinum porphyrin compounds) are quenched in the presence of oxygen. Higher oxygen levels reduce fluorescence intensity and shorten fluorescence lifetime. By embedding these dyes in sensor spots or coating microchannels, researchers can map oxygen gradients across chips with micrometer resolution.
Applications in Drug Discovery
Mitochondrial Toxicity: Drugs that inhibit mitochondrial respiration cause decreased oxygen consumption - a sensitive early marker of toxicity.
Hypoxia Modeling: Tumors, ischemic tissue, and stem cell niches exist at low oxygen. Sensors verify physiologically relevant oxygen levels.
Metabolic Phenotyping: Cancer cells often show the Warburg effect (glycolysis over oxidative phosphorylation). Oxygen sensors quantify this metabolic shift.
Organ Viability: Sudden drops in oxygen consumption indicate cell death or loss of function in organ models.
0-21%
Detection range (% O2)
0.1%
Resolution achievable
Non-invasive
Optical readthrough
Continuous
24/7 monitoring
pH Monitoring
Cellular metabolism produces acidic byproducts, making pH a sensitive indicator of metabolic activity and cell health. In organ-on-chip systems, pH monitoring reveals real-time metabolic states and drug effects.
pH Sensing Technologies
Optical pH Sensors: Fluorescent indicators like SNARF, BCECF, or HPTS change emission spectra with pH. Ratiometric measurement (comparing two wavelengths) compensates for variations in dye concentration or photobleaching.
ISFET Sensors: Ion-Sensitive Field Effect Transistors directly measure hydrogen ion concentration electrochemically. Highly miniaturizable and compatible with CMOS fabrication.
Hydrogel Sensors: pH-responsive hydrogels change volume or optical properties, enabling colorimetric or mechanical readouts.
Why pH Matters
Metabolically active cells acidify their environment through lactic acid production (glycolysis) and CO2 release (respiration). Tracking pH dynamics reveals:
Metabolic rate changes in response to drugs
Shift from oxidative phosphorylation to glycolysis (Warburg effect in cancer)
Cell stress and early apoptosis indicators
Drug effects on acid-base transporters
Glucose and Lactate Sensing
Glucose consumption and lactate production are primary indicators of cellular metabolism. Electrochemical enzymatic sensors enable continuous monitoring of these critical metabolites in organ-on-chip systems.
Electrochemical Biosensor Principle
Enzyme-based sensors use specific oxidases (glucose oxidase, lactate oxidase) that catalyze reactions producing hydrogen peroxide. The peroxide is electrochemically oxidized at a platinum electrode, generating current proportional to metabolite concentration.
Lactate Production: Elevated lactate signals shift to anaerobic glycolysis - common in hypoxia, cancer, and mitochondrial dysfunction
Lactate/Glucose Ratio: This metabolic ratio distinguishes oxidative vs. glycolytic phenotypes
Drug Effects: Compounds affecting metabolic enzymes, transporters, or mitochondria alter glucose/lactate dynamics within hours
Impedance Spectroscopy
Electrical impedance spectroscopy applies small AC voltages across a frequency range to cells on electrodes, measuring the resulting current. The impedance spectrum contains rich information about cell morphology, attachment, and viability - all without labels or sample consumption.
What Impedance Reveals
Cell Attachment & Spreading: As cells attach and spread on electrodes, they block ionic current, increasing impedance. Monitors cell seeding and adhesion dynamics.
Cell Proliferation: Growing cell populations progressively cover electrode surface, reflected in rising impedance over days.
Cell Death: Dying cells detach or become permeable, causing impedance to drop. Detects cytotoxicity in real-time.
Barrier Formation: At low frequencies, impedance measures current flow between cells (paracellular), reflecting tight junction integrity - the basis for TEER.
Cell Membrane Capacitance: High-frequency components reflect membrane properties, revealing drug effects on membrane composition or fluidity.
Researchers at MIT developed a heart-on-chip with integrated oxygen sensors, pH sensors, and impedance electrodes. When exposed to doxorubicin (a chemotherapy drug known to cause heart damage), the multi-sensor array detected metabolic changes 24 hours before contractile dysfunction became apparent. The oxygen consumption dropped first, followed by pH acidification, then impedance changes correlating with cardiomyocyte death.
24 hrs
Earlier detection than traditional methods
5
Parameters monitored simultaneously
92%
Prediction accuracy for cardiotoxicity
10x
Data density vs. endpoint assays
Comprehensive Cell Health Monitoring
No single sensor captures the full picture of cell health. Modern organ-on-chip platforms integrate multiple sensor types to create a holistic view of cellular status, enabling earlier and more accurate detection of drug effects.
Multi-Parameter Monitoring Strategy
Metabolic Health
Oxygen consumption, glucose uptake, lactate production, and pH changes reveal the metabolic state and mitochondrial function of cells.
Sensors: O2, glucose, lactate, pH
Barrier Integrity
TEER and impedance spectroscopy monitor tight junction formation and paracellular permeability in epithelial/endothelial models.
Sensors: TEER electrodes, EIS
Morphology & Viability
Impedance changes reflect cell attachment, spreading, proliferation, and death without labels or imaging.
Sensors: Impedance at multiple frequencies
Functional Readouts
Tissue-specific sensors measure contractility (heart), albumin secretion (liver), or electrical activity (neurons).
Sensors: MEAs, biosecretion, mechanical
AI-Integrated Sensing
The volume and complexity of data from multi-sensor arrays exceeds human analytical capacity. Artificial intelligence and machine learning are transforming biosensor data into actionable insights for drug discovery.
AI Capabilities for Biosensor Analysis
Pattern Recognition
Identify toxicity signatures from multi-parameter sensor data
Early Prediction
Forecast outcomes hours before traditional endpoints
Anomaly Detection
Flag unexpected sensor readings or system failures
Phenotype Classification
Categorize drug responses into mechanism-based classes
Machine Learning Applications
Toxicity Prediction: Neural networks trained on historical sensor data predict cytotoxicity with 85-95% accuracy from early timepoints
Mechanism of Action: Clustering algorithms group compounds with similar sensor signatures, revealing shared mechanisms
Quality Control: Anomaly detection identifies batch variations, sensor drift, or contamination in real-time
Dose-Response Modeling: AI extracts EC50/IC50 values from continuous sensor data with greater precision than endpoint measurements
Miniaturization Trends
Advances in microfabrication and nanomaterials are enabling smaller, more sensitive, and more integrated biosensors for organ-on-chip applications.
Nanomaterial Electrodes
Carbon nanotubes, graphene, and gold nanoparticles dramatically increase electrode surface area and sensitivity while reducing size. Detection limits reach femtomolar concentrations.
CMOS Integration
Semiconductor fabrication enables electrode arrays with thousands of sensors and integrated signal processing on a single chip, reducing costs and enabling high-throughput screening.
3D Printed Sensors
Additive manufacturing creates complex 3D electrode geometries and enables rapid prototyping of custom sensor configurations for specific organ models.
Wireless & Wearable
Bluetooth-enabled sensor modules and flexible substrates enable monitoring of organ-on-chip in incubators without cable connections, improving usability.
Multiplexed Arrays
Single chips now integrate 8-16 different sensor types, enabling comprehensive metabolic profiling from minimal sample volumes in multi-organ systems.
Self-Calibrating Sensors
Built-in reference electrodes and AI drift correction enable long-term stability without manual recalibration, critical for week-long organ-on-chip experiments.
Key Companies in Biosensor Technology
The biosensor ecosystem spans established diagnostics companies, organ-on-chip pioneers, and specialized sensor developers.
EmulateOrgan-on-Chip + Sensors
TissUseMulti-Organ + TEER
MimetasOrganoPlate
CN BioPhysioMimix
HesperosMulti-Sensor Body-on-Chip
Axion BioSystemsMEA Systems
Applied BiophysicsECIS Impedance
PreSensOptical O2/pH
AgilentSeahorse Metabolic
ACEA/AgilentxCELLigence Impedance
SenzaGenGARDskin
NcardiaCardiac Sensors
Frequently Asked Questions
What are biosensors in organ-on-chip systems?
Biosensors in organ-on-chip systems are miniaturized analytical devices that convert biological or chemical responses into measurable electrical, optical, or mechanical signals. They enable real-time, non-invasive monitoring of cell health, metabolic activity, barrier integrity, and drug responses within microfluidic organ models. Common types include electrochemical sensors for metabolites, optical sensors for oxygen and pH, and electrical impedance sensors for cell barrier function (TEER).
What is TEER measurement and why is it important?
TEER (Trans-Epithelial/Endothelial Electrical Resistance) measures the electrical resistance across a cell layer, indicating tight junction integrity and barrier function. It is critical for organ-on-chip models of the intestine, blood-brain barrier, lung, and skin where barrier integrity determines drug absorption and toxicity. TEER values typically range from 150-400 ohm-cm2 for intestinal models and 1500+ ohm-cm2 for blood-brain barrier models.
How do electrochemical biosensors work?
Electrochemical biosensors use enzyme-coated electrodes to detect specific metabolites. For example, glucose sensors use glucose oxidase enzyme that generates electrons when glucose is present, producing a measurable current proportional to glucose concentration. Similarly, lactate oxidase detects lactate production indicating anaerobic metabolism or cell stress. These sensors can achieve detection limits as low as micromolar concentrations.
What types of optical biosensors are used?
Optical biosensors in organ-on-chip include: oxygen-sensitive fluorescent dyes (ruthenium or platinum porphyrin compounds) that quench in the presence of oxygen; pH-sensitive fluorophores like SNARF or BCECF that change emission spectra with pH; calcium indicators for monitoring cellular signaling; and surface plasmon resonance (SPR) sensors for detecting molecular binding events.
What is impedance spectroscopy?
Impedance spectroscopy applies small AC voltages across frequency ranges (typically 1 Hz to 1 MHz) to cells on electrodes, measuring the resulting current. The impedance spectrum reveals cell attachment, spreading, proliferation, and death. High frequencies probe cell membrane capacitance, while low frequencies assess cell-cell junctions. This label-free technique can detect cytotoxicity and drug effects in real-time.
How are biosensors miniaturized for chip integration?
Biosensor miniaturization uses microfabrication techniques including photolithography to pattern microelectrodes on glass or silicon, screen printing for low-cost electrode arrays, inkjet printing of enzyme layers, and MEMS for mechanical sensors. Advances in nanomaterials like carbon nanotubes, graphene, and gold nanoparticles enhance sensitivity while reducing sensor size.
What role does AI play in biosensor data analysis?
AI and machine learning analyze the complex, multi-dimensional data streams from integrated biosensor arrays. Algorithms can correlate multiple parameters to identify drug toxicity signatures, predict cell viability from early metabolic changes, detect anomalies indicating contamination or device failure, and classify drug response phenotypes. Deep learning models can predict outcomes hours before traditional endpoints.
Which companies lead biosensor development for organ-on-chip?
Key players include Emulate (integrated sensors in human-on-chip), TissUse (multi-organ platforms with TEER), Mimetas (OrganoPlate with embedded electrodes), CN Bio (PhysioMimix with real-time sensing), Hesperos (multi-sensor body-on-chip), Axion BioSystems (MEA neural sensors), Applied Biophysics (ECIS impedance systems), and PreSens (optical oxygen/pH sensors).
Explore Biosensor Simulations
Experience real-time cell monitoring in our interactive organ-on-chip laboratory
Grand View Research. "Biosensors Market Size, Share & Trends Analysis Report By Technology, By Application, By End-use, By Region, And Segment Forecasts, 2021-2028." Market Research Report, 2021. grandviewresearch.com
Zhang YS, et al. "Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors." PNAS. 2017;114(12):E2293-E2302. doi:10.1073/pnas.1612906114. PMID: 28265064.
Bavli D, et al. "Real-time monitoring of metabolic function in liver-on-chip microdevices tracks the dynamics of mitochondrial dysfunction." PNAS. 2016;113(16):E2231-E2240. doi:10.1073/pnas.1522556113. PMID: 27044092.
Kilic T, et al. "Organs-on-chip monitoring: sensors and other strategies." Microphysiological Systems. 2018;2:5. doi:10.21037/mps.2018.01.01